包装D1
常染色体显性多囊肾病
种系突变
生物
多囊肾病
体细胞
睫状体病
囊肿
遗传学
癌症研究
突变
肾
病理
基因
医学
表型
作者
Adrian Y. Tan,Tuo Zhang,Alber Michaeel,Jon D. Blumenfeld,Genyan Liu,Wanying Zhang,Zhengmao Zhang,Yi Zhu,Lior Rennert,Che Martin,Jenny Xiang,Steven Salvatore,Brian D. Robinson,Sandip Kapur,Stephanie Donahue,Warren O. Bobb,Hanna Rennert
出处
期刊:Journal of The American Society of Nephrology
日期:2018-07-24
卷期号:29 (8): 2139-2156
被引量:50
标识
DOI:10.1681/asn.2017080878
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is a ciliopathy caused by mutations in PKD1 and PKD2 that is characterized by renal tubular epithelial cell proliferation and progressive CKD. Although the molecular mechanisms involved in cystogenesis are not established, concurrent inactivating constitutional and somatic mutations in ADPKD genes in cyst epithelium have been proposed as a cellular recessive mechanism.We characterized, by whole-exome sequencing (WES) and long-range PCR techniques, the somatic mutations in PKD1 and PKD2 genes in renal epithelial cells from 83 kidney cysts obtained from nine patients with ADPKD, for whom a constitutional mutation in PKD1 or PKD2 was identified.Complete sequencing data by long-range PCR and WES was available for 63 and 65 cysts, respectively. Private somatic mutations of PKD1 or PKD2 were identified in all patients and in 90% of the cysts analyzed; 90% of these mutations were truncating, splice site, or in-frame variations predicted to be pathogenic mutations. No trans-heterozygous mutations of PKD1 or PKD2 genes were identified. Copy number changes of PKD1 ranging from 151 bp to 28 kb were observed in 12% of the cysts. WES also identified significant mutations in 53 non-PKD1/2 genes, including other ciliopathy genes and cancer-related genes.These findings support a cellular recessive mechanism for cyst formation in ADPKD caused primarily by inactivating constitutional and somatic mutations of PKD1 or PKD2 in kidney cyst epithelium. The potential interactions of these genes with other ciliopathy- and cancer-related genes to influence ADPKD severity merits further evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI